Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4396 USD | -0.54% | +2.23% | -40.60% |
26/03 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
26/03 | US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings | MT |
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.65M 138M |
---|---|---|---|---|---|
Net income 2023 * | -12M -1B | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.06
x | P/E ratio 2024 * |
-
| Employees | 37 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
Latest transcript on NeuBase Therapeutics, Inc.
1 day | -0.54% | ||
1 week | +2.23% | ||
Current month | -2.29% | ||
1 month | +1.13% | ||
3 months | -30.28% | ||
6 months | -26.73% | ||
Current year | -40.60% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 10/22/10 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 12/19/12 |
Eric Richman
BRD | Director/Board Member | 63 | 12/19/12 |
Director/Board Member | 79 | 12/19/12 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.4396 | -0.54% | 72,170 |
25/24/25 | 0.442 | +4.99% | 25,641 |
24/24/24 | 0.421 | 0.00% | 21,218 |
23/24/23 | 0.421 | +0.24% | 58,425 |
22/24/22 | 0.42 | -2.33% | 157,792 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-40.60% | 1.65M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NBSE Stock